Overview

This trial is active, not recruiting.

Condition dental adhesive
Treatment adhese one f upgrade
Sponsor Ivoclar Vivadent AG
Start date June 2012
End date June 2015
Trial size 28 participants
Trial identifier NCT02175368, AOFU 2012

Summary

Investigation on the clinical performance of a new dental adhesive when used in direct filling therapy after phosphoric acid etching.

Hypothesis: The new adhesive shows an acceptable clinical performance and allows a good filling quality.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Intervention model single group assignment
Masking open label
Primary purpose treatment
Arm
(Experimental)
Adhese One F Upgrade (AOFU) is administered after phosphoric acid etching (etch-and-rinse protocol).
adhese one f upgrade

Primary Outcomes

Measure
Number of participants with clinical success
time frame: 1 week

Secondary Outcomes

Measure
Clinical quality
time frame: 1 week, 1 year, 2 years, 3 years

Eligibility Criteria

Male or female participants from 18 years up to 65 years old.

Inclusion Criteria: - indication for class I or II filling - max. 2 restorations per patient - vital teeth - sufficient language skills Exclusion Criteria: - dry working field cannot be established - if the patient is known to be allergic to any of the materials` ingredients - severe systemic diseases - pregnancy - non-vital or pulpitic teeth - indication for indirect restoration

Additional Information

Official title Clinical Evaluation of AdheSE One F Upgrade in Direct Filling Therapy
Principal investigator Arnd Peschke, Dr.
Trial information was received from ClinicalTrials.gov and was last updated in August 2016.
Information provided to ClinicalTrials.gov by Ivoclar Vivadent AG.